Research Papers

25 of 1719 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
The Efficacy and Safety of Nirmatrelvir/Ritonavir Against COVID-19 in Elderly Patients.
Xiang Z; Wang Y; Qu Y; Lv B; Han J; Xu D; Fan K; Su C; Shen Z.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Treatment of Depression with Acupuncture Based on Pathophysiological Mechanism.
Sun B; Cao X; Xin M; Guan R.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Trabecular Bone Score Improves Fracture Risk Discrimination in Postmenopausal Rheumatoid Arthritis Patients Receiving G…
Ruangnopparut R; Charoensri S; Sribenjalak D; Theerakulpisut D; Pongchaiyakul C.
Int J Gen Med (Unknown)
Published: 2024
2/6 Transparent
Clinical Characteristics of Children Infected with SARS-CoV-2 Omicron (B.1.1.529) in China's Shanghai.
Shu J; Jia L; Zhang P; Wang R; Wang M; Sun X; Peng Y; Wang P; Li X; Tang Z; Han T; Ju T; Wei Y; Pang W; Gao C; Xia Z.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Door-to-Balloon Time and Mortality Among Patients Undergoing Primary PCI, Challenges and Experience from Somalia's Larg…
Hassan MO; Ahmed SA; Hassan MS; Köprülü D.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Magnetic Resonance Imaging Findings and Their Association with Electroencephalographic Data in Children with Epilepsy a…
Elmi AM; Ibrahim AA; Hassan MS; Osman FAO; Çelik C; Dirie AM; Ibrahim IG.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Drug-Coated Balloon for de-novo Coronary Artery Lesions Exceeding 2.5 mm in Diameter: Optical Coherence Tomography Anal…
Liu Y; Zhang B; Lv H; Zhu Y; Zhou X; Zhu H; Guo L.
Int J Gen Med (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Mo…
Duan H; Shen Y; Wang C; Xia W; Zhang S; Yu S; Xu D; Cao Q; Liu H; Shen H.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Cross-Sectional Evaluation of Knowledge of Medicine Safety and Frequency of Reading Medication Leaflets and Its Predi…
Alghamdi A; Qadhi OA; Syed W; Samarkandi OA; Basil A Al-Rawi M.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Clinical Application of a New Cesarean Scar Pregnancy Classification and Evaluation System and a Risk Scoring System.
Fu P; Zhang L; Zhou T; Wang S; Liu R.
Int J Gen Med (Unknown)
Published: 2024
2/6 Transparent
Malignancy in a Solitary Thyroid Nodule: A Retrospective Histopathological Evaluation.
Alzahrani HA.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
High Ferritin and Low Total Iron-Binding Capacity in Plasma Predict All-Cause Mortality During the First 3 Years of Hem…
Nguyen Thi Thu H; Nguyen Van H; Nguyen Minh T; Nguyen Trung K; Le Viet T.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Establishment of an Evaluation Index System of Competencies for College Senior Students in General Practice Medicine in…
Zhao R; Liu F; Zhu K.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Fatigue, Physical Activity, and Quality of Life in Patients with Inflammatory Bowel Disease: A Cross-Sectional Study.
Qiao R; Zhou Y; Ding T; Jiang X.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The Influence of Obesity on Bone Health in Post-COVID-19 Recovery- Single-Center Experience.
Chaturvedi B; Debnath S; Bareth H; Raj P; Singh P; Singh M; Nathiya D; Tomar BS.
Int J Gen Med (Unknown)
Published: 2024
2/6 Transparent
Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies.
Alkhatabi HA; Alqahtani W; Alsolami R; Elaimi A; Hazzazi MS; Almashjary MN; Alkhatabi HA; Alghuthami ME; Daous YM; Yasin EB; Barefah A.
Int J Gen Med (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart…
He X; Jiang Y; Li S; Liu D; Li Z; Han X; Zhang X; Dong X; Liu H; Huang J; Wang X; Long W; Ni S; Yang Z; Ye T.
Int J Gen Med (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Analysis of the Risk Factors for Negative Emotions in Patients with Esophageal Cancer During the Peri-Radiotherapy Peri…
Luo F; Lu Y; Chen C; Chang D; Jiang W; Yin R.
Int J Gen Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of Risk Factors for Negative Emotions in the Perioperative Period in Patients with Benign Ovarian Cysts Treate…
Wu M; Xie X; Jiang Q.
Int J Gen Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Coagulation Parameters in Post-Covid-19 Condition in Relation to Various Titers of Anti-SARS-CoV-2 IgG in Blood Plasma.
Strubchevska K; Rachkovska A; Krenytska D; Karbovskyy V; Kozyk M; Secor B; Raksha N; Vovk T; Savchuk O; Falalyeyeva T; Kaminsky R; Ostapchenko L.
Int J Gen Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Healthcare Workers' Vulnerability to SARS-CoV-2 in Western Romania: A Study on Incidence and Risk Factors for Non-Vacci…
Popescu IM.
Int J Gen Med (Unknown)
Published: 2023
2/6 Transparent
Further Refinement is Required for Patient-Reported Outcome Scales for Respiratory Diseases Based on Traditional Chines…
Zhang P; Ren J; Xu B; Wang J; Xie Y.
Int J Gen Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Correlation Between Lipoprotein-Related Phospholipase A2 and Metabolic Syndrome.
Wang KY; Chen YC; Chen JY; Loke SS; Yeh WC; Li WC.
Int J Gen Med (Unknown)
Published: 2023
2/6 Transparent
Utilization of HIV Pre-exposure Prophylaxis and Associated Factors Among Female Sex Workers in Bahir Dar City, North-We…
Ademe B; Bogale EK; Anagaw TF.
Int J Gen Med (Unknown)
Published: 2023
2/6 Transparent
Analysis of Related Risk Factors and Prognostic Factors of Gastric Cancer with Liver Metastasis: A SEER and External Va…
An W; Bao L; Wang C; Zheng M; Zhao Y.
Int J Gen Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared